Literature DB >> 8466308

Peptic ulcer surgery in patients with liver cirrhosis.

T Lehnert1, C Herfarth.   

Abstract

OBJECTIVE: This study identified risk factors of surgical treatment for gastroduodenal ulcer disease in patients with liver cirrhosis. SUMMARY BACKGROUND DATA: Liver cirrhosis is frequently associated with complicated peptic ulcer disease. Surgery in liver cirrhotics has a high mortality and morbidity especially when abdominal operations are performed.
METHODS: Sixty-nine patients undergoing surgery for gastroduodenal ulcer disease between 1972 and 1991 were studied, retrospectively.
RESULTS: Ninety percent of patients required emergency surgery for bleeding ulcer (n = 45) or perforation (n = 17). Mortality was 29% for elective patients (n = 7), 35% for patients with perforation and 64% for patients with bleeding. Overall mortality of 69 patients was 54%. Only 15 of 69 patients (22%) had an uncomplicated postoperative course. Postoperative bleeding, septic complications, and renal failure were the most frequent postoperative complications. Bleeding and multiple organ failure were the leading causes of death in 70% of patients. A univariate analysis determined preoperative hemoglobin < 12 g/L (p < 0.05), systolic blood pressure < 100 mm Hg (p < 0.025), prothrombin time < 60% (p < 0.05) and the presence of portal hypertension (p < 0.01) as prognostic factors. No significant correlation with survival could be established for excretory liver function (serum bilirubin) and partial thromboplastin time.
CONCLUSIONS: To improve treatment results it is recommended (1) to substitute blood products (particularly coagulation factors) early and in sufficient quantities, (2) to diligently search for and to treat septic foci and administer antibiotics in a nonrestrictive manner, and (3) to restrict the operative procedure to the treatment required for control of the ulcer complication.

Entities:  

Mesh:

Year:  1993        PMID: 8466308      PMCID: PMC1242800          DOI: 10.1097/00000658-199304000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  42 in total

1.  The liver's role in histamine absorption from the alimentary tract; its possible importance in cirrhosis.

Authors:  W T IRVINE; H L DUTHIE; H D RITCHIE; N G WATON
Journal:  Lancet       Date:  1959-05-23       Impact factor: 79.321

2.  [Pattern of serum liver enzymes following gastric surgery].

Authors:  G F Otto; W L Brückner
Journal:  Med Klin       Date:  1971-11-19

3.  [Enzymologic study of the problem of postoperatice liver damage].

Authors:  C Herfarth
Journal:  Bruns Beitr Klin Chir (1971)       Date:  1968-10

4.  Improving survival in patients with cirrhosis undergoing major abdominal operations.

Authors:  K R Sirinek; R R Burk; M Brown; B A Levine
Journal:  Arch Surg       Date:  1987-03

5.  Gastric acid secretion and gastrin and gastric inhibitory polypeptide release in cirrhotic patients.

Authors:  T Sato; M Imamura; I Sasaki; A Ohneda
Journal:  Am J Gastroenterol       Date:  1985-03       Impact factor: 10.864

6.  Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.

Authors:  G H Brunner; R Lamberts; W Creutzfeldt
Journal:  Digestion       Date:  1990       Impact factor: 3.216

7.  Concordant occurrence of gastric and hypertensive diseases.

Authors:  A Sonnenberg
Journal:  Gastroenterology       Date:  1988-07       Impact factor: 22.682

8.  Late mortality after surgery for peptic ulcer.

Authors:  A H Ross; M A Smith; J R Anderson; W P Small
Journal:  N Engl J Med       Date:  1982-08-26       Impact factor: 91.245

9.  Intra-abdominal surgery in patients with advanced cirrhosis.

Authors:  G V Aranha; H B Greenlee
Journal:  Arch Surg       Date:  1986-03

10.  Biliary tract surgery and cirrhosis: a critical combination.

Authors:  S I Schwartz
Journal:  Surgery       Date:  1981-10       Impact factor: 3.982

View more
  8 in total

Review 1.  Non-variceal gastrointestinal bleeding in patients with liver cirrhosis: a review.

Authors:  M Kalafateli; C K Triantos; V Nikolopoulou; A Burroughs
Journal:  Dig Dis Sci       Date:  2012-06-04       Impact factor: 3.199

2.  Major abdominal cancer resections in cirrhotic patients: how frequent is postoperative hepatocellular decompensation?

Authors:  Shailesh Vinayak Shrikhande; Vinay Gaikwad; Dipak Purohit; Mahesh Goel
Journal:  Indian J Gastroenterol       Date:  2013-11-12

3.  Risk factors for nonhepatic surgery in patients with cirrhosis.

Authors:  Juan A del Olmo; Blas Flor-Lorente; Blas Flor-Civera; Felicidad Rodriguez; Miguel A Serra; Amparo Escudero; Salvador Lledó; José M Rodrigo
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

4.  Influence of age, comorbidity, type of operation and other variables on lethality and duration of post-operative hospital stay in patients with peptic ulcer. An analysis of 303 surgically treated patients.

Authors:  J Högel; R J Rieker; R Eisele; E Schmid
Journal:  Langenbecks Arch Chir       Date:  1996

5.  Preoperative transjugular intrahepatic portosystemic shunt (TIPS) for cirrhotic patients undergoing abdominal and pelvic surgeries.

Authors:  Christine Schlenker; Stephen Johnson; James F Trotter
Journal:  Surg Endosc       Date:  2009-03-05       Impact factor: 4.584

Review 6.  Outcomes of patients with cirrhosis undergoing non-hepatic surgery: risk assessment and management.

Authors:  Farida Millwala; Geoffrey C Nguyen; Paul J Thuluvath
Journal:  World J Gastroenterol       Date:  2007-08-14       Impact factor: 5.742

7.  The critically ill patient after hepatobiliary surgery.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

8.  Perioperative risk of hip arthroplasty in patients with cirrhotic liver disease.

Authors:  Young-Wan Moon; Yong-Sik Kim; Soon-Yong Kwon; Shin-Yoon Kim; Seung-Jae Lim; Youn-Soo Park
Journal:  J Korean Med Sci       Date:  2007-04       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.